Arab Health Expo Review





It’s huge – 4000 exhibitors and
130,000 healthcare professionals
from 163 countries


 

The 41st Arab Health Exhibition and Congress took place from 25-28 January at Dubai International Convention & Exhibition Centre. It is the largest and most prestigious medical trade fair in the Middle East with more than 4,000 companies exhibiting their latest innovations to more than 130,000 healthcare professionals from 163 countries.

As the Middle East healthcare industry continues its trend of rapid growth on the back of continued investment in healthcare infrastructure, Arab Health provides an ideal platform for the world’s leading healthcare manufacturers, wholesalers and distributors to meet the medical and scientific community in the Middle East and subcontinent.

In addition to the exhibition, the Arab Health Congress is renowned for delivering.

 

RoboDocs

To coincide with Arab Health, Dubai Health Authority (DHA) announced the pilot launch of a telehealth project, to extend the use of RoboDocs to ICUs, and NICUs. The telehealth project will enhance the way in which healthcare is delivered in the Emirate. Amani Al Jassmi, Director of Information Technology at the DHA, said: “The DHA is the first government health organization in the region to implement telehealth. This project is in line with the vision of Dubai Smart City and it is one of the core projects for the DHA because telehealth can ensure consistent high quality of care, anytime, anywhere and any place due to the remote robot systems.


National Reference Laboratory and LabCorp pave the way for personalized medicine in the region

National Reference Laboratory, part of Mubadala’s network of healthcare providers, introduced several world-class assays in the domain of hereditary genetics and therapeutic oncology, available through its partner LabCorp and the members of the LabCorp Specialty Testing Group during MEDLAB 2016, as part of the Arab Health 2016 Exhibition & Congress that took place from 25-28 January at Dubai International Convention & Exhibition Centre.

Over the past few years, the region has seen an increased need for specialized healthcare services, including oncology and genetics, resulting in the rapid development of in vitro diagnostics and personalized medicine. Specialized facilities such as National Reference Laboratory are closely following and supporting the development of healthcare infrastructure in the country and the region by offering tests used as diagnostic and prognostic tools for monitoring and treating a variety of acquired and hereditary diseases, including cancers.

“The advancement in Polymerase Chain Reaction (PCR) techniques combined with the introduction of Next Generation Sequencing (NGS), has led to a noticeable increase in laboratory testing in the domains of genetics, pharmacogenetics, and oncology. Based on the unique genetic profile of each individual, we are able to make medical decisions for the specific patient in order to predict risk of disease as well as failure and/or response to treatment,” said Abdul Hamid Oubeisi, CEO of National Reference Laboratory. “Similarly, these new methodologies have lowered the costs and therefore made the tests more accessible. We are pleased that through our partnership with LabCorp USA, we are able to provide this type of sophisticated testing to patients in the region.”

Assays promoted during MedLab 2016 included the VistaSeq Hereditary Cancer Panel; IntelliGENSM Oncology Therapeutic Panel NGS Assay and BRCAssure - genetic testing for the presence of BRCA1/2 mutations which can help provide information about the risk for developing breast cancer, ovarian or other cancers.

About National Reference Laboratory

National Reference Laboratory is a Mubadala Company created in partnership with Laboratory Corporation of America Holdings (LabCorp), the world’s leading healthcare diagnostics company and operator of one of the world’s largest and most experienced clinical laboratory networks.

National Reference Laboratory’s vision is to increase the spectrum, coverage and overall efficiency of laboratory testing in the region, to implement international best practice reference laboratory processes and to set the benchmark for quality standards in the region. Together with the significant resources of LabCorp, National Reference Laboratory offers a comprehensive menu of more than 5,000 tests, providing a complete solution for all clinical testing needs in an efficient and high-quality environment that reduces both turnaround time and logistics-related costs, compared with other referral laboratories. Through its commitment to a comprehensive Quality Management System (QMS), investment in state-of-the-art technologies, superior connectivity solutions, advanced logistics systems and the engagement of highly-skilled and experienced employees National Reference Laboratory has attained and maintained a position as a trusted resource for all healthcare providers and patients in the region.

NRL owns two laboratories in Abu Dhabi and Dubai and manages the laboratory of Healthpoint Hospital in Abu Dhabi as well as the laboratories of Imperial College London Diabetes Centre in Abu Dhabi and Al Ain. In partnership with Cleveland Clinic Abu Dhabi, NRL manages the technical component of the joint Anatomic Pathology laboratory and is responsible for all CCAD laboratory referral testing.

Building on the current laboratory management model, National Reference Laboratory continues to grow the network of managed facilities with plans to become the largest network of CAPaccredited laboratories in the region.


HMC showcases Hamad Healthcare Quality Institute

Qatar’s Hamad Medical Corporation (HMC) showcased the Hamad Healthcare Quality Institute (HHQI) at the Arab Health exhibition with the aim of building a network of regional healthcare providers in order to better understand and act on challenges faced by caregivers in the GCC.

HMC established HHQI with the purpose of improving the quality of healthcare within HMC, the State of Qatar and the greater region.

Nasser Saeed Al Naimi, Deputy Chief Quality Officer and Co-Director for Hamad Healthcare Quality Institute (HHQI), said that HMC was committed to continuing its journey of quality improvement: “The Institute was created to introduce the latest innovations and evidence-based healthcare solutions. HHQI embraces the roles of innovation, design, improvement, research, training and implementation, to create a first-ofits kind resource in the region that enables sustainable healthcare improvement.”

In addition to expanding its regional network of healthcare providers, HHQI used the exhibition as a platform to announce the fourth Middle East Forum on Quality and Safety in Healthcare (ME Forum), the leading healthcare quality improvement conference in the region.

Led by HMC’s Hamad Healthcare Quality Institute (HHQI), the annual conference will be held from 13-15 May 2016 at Qatar National Convention Centre in Doha, and reinforces the partnership between HMC and the US-based Institute for Healthcare Improvement, a not-for-profit organization that is a leading innovator in health and healthcare improvement worldwide.


KEF-TAHPI shows modular hospital concept

KEF-TAHPI showcased its ‘Catalogue Hospitals’ concept at the Arab Health Exhibition. It featured a realistic modular display of three standard hospital room types including an inpatient bedroom, bathroom and utility room that builds on the company’s effective modular design and construction model.

The KEF-TAHPI Design Studio, a joint venture of KEF Holdings, a UAEbased holdings group and Australia-based TAHPI noted that this modular hospital concept provides quick turnaround, costeffective construction and quality control which are key to reducing the healthcare infrastructure gap in the region an increasing access to healthcare.

Aladin Niazmand, CEO, KEF-TAHPI, said: “Access to good hospitals and healthcare facilities is a basic human right that countries are seeking to provide to citizens. However, demand from increasing populations in the Middle East and India far outstrips supply of durable, affordable, quality infrastructure. KEF-TAHPI Design Studio’s cost and time-effective modular solutions cater to this supply gap for smart infrastructure offerings in the healthcare industry.”

Offering an ‘assemble rather than build’ solution, KEF-TAHPI seeks to bring about a disruptive paradigm change in healthcare infrastructure development. The company’s revolutionary industrialized approach to healthcare design and modular construction offers clients the convenience of choosing design options from a design catalogue with a view to reducing project costs and timeframe of implementation by almost 50%.

The KEF-TAHPI Design Studio is currently overseeing the construction of its pilot project – a 500-bed tertiary hospital in Calicut. The PMHP Hospital, India’s first healthcare facility designed and built completely offsite. The project is scheduled for completion in Q3 of 2016, less than two years since construction began compared to the four- to five-year industry average that it takes to build a healthcare facility using conventional construction methods.

Highlighting KEF’s use of advanced robotic technology, the stand also featured one of the robots to be used at KEF’s upcoming $100-million Jebel Ali manufacturing facility. The KEF-TAHPI Design Studio is located in Dubai Healthcare City.


Philips connects the dots

Middle East Health’s Kathryn Hansbro speaks
to Arjen Radder, Philips CEO Middle East
and Turkey about their healthcare continuum.

It was all about empowering people and making health personal at the Philips booth this year.

The company showcased its range of range of connected solutions across the ‘health continuum’ – healthy living, prevention, diagnosis, treatment and care at home.

The aim is to provide more predictive and more
personalised care to enable people to take charge of their own health, as well as first-time-right diagnoses and more effective treatments.

Arjen Radder, Philips CEO Middle East and Turkey, told Middle East Health: “There is an increasingly ageing population, we are going from acute diseases to chronic diseases, and home care is becoming more and more important. At the other end of the spectrum you also have to make sure you invest in healthy living and also in prevention.

“With more people ageing there will be pressure on the health system; we have to provide better health care at a lower cost. The health continuum is our way of dealing with all these challenges.

“One of the key things recently was an agreement with the Ministry of Health here in the UAE, where we are monitoring patients in Intensive Care Units (ICU) around the clock, this is very important. It’s easier in terms of care, as we can monitor them from a remote location. We still have access to all the important data and therefore we can move people from intensive care to the ward to their homes much faster; it’s a better outcome at a lower cost.”

Philips is working with the Ministry to expand the programme across a number of medical facilities in the coming months; it is currently fully operational in two hospitals in the UAE.

Radder added: “We also have the personal health solutions, this is where you can invest in your own health, healthy living and also in prevention. If you look at what’s happening in the region, apart from ageing and the vast increase of chronic diseases, people are taking more care of their own health; they are wearing devices that measure something relating to their personal health, such as glucose levels, blood pressure or weight. You can make data meaningful and you can motivate people. And of course you can start to combine that with medical data. It’s a strong enabler for connecting the five different steps on the health continuum.

“The other thing is our smart ultrasound device (Lumify), where previously you had to go to a hospital and there was quite a sizeable system standing next to you checking your baby this portable cloud-based real-time device actually brings ultrasound anywhere – to places it’s never been before, it can come into the home, a GP can use this small device.

“I view 2016 as an area of excitement and opportunity in the region. However, awareness is more limited than it should be. Some 45% of women are obese in Oman, Qatar and the UAE. There are 35 million diabetes patients in MENA (Middle East and North Africa region) and over the next 20 years the figure is expected to be 70 million. Data shows demand for healthcare over the next two decades will increase by 240%. This is an excellent region to be talking about the health continuum, and an excellent opportunity to talk about better care.”

Connected solutions on show

Telehealth programmes

The Philips Tele-ICU programme aims to clinically transform the ICU by using a proactive care model that provides a solution to growing physician and nurse shortages while dramatically improving quality of care. This model is aimed at leveraging clinical expertise, patented processes, and cutting-edge technologies to improve critical care delivery 24/7.

Philips Perosonal Healthcare Programmes

These app-based solutions help people establish and maintain healthier habits. They are designed with a unique combination of professional healthcare and consumer insights. The Philips health watch, for example, empowers individuals to live a healthier life by tracking heart rate and other metrics of their cardio condition, as well as activity, sleep and more.

The solutions are enabled by the Philips Health Suite Digital Platform, an open, secure, cloud-based platform that pulls together the vast amounts of data produced by digital solutions, including third party devices, traditional medical data sources and medical images.

IntelliSpace Portal 8.0.

The advanced data sharing, analytics and visualisation platform helps radiologists detect, diagnose and follow-up on cancer treatment. IntelliSpace Portal 8.0 helps address the changing demands in radiology that result from an increasing prevalence of cancer and its economic toll.

Lumify

The smart device solution is set to make ultrasound technology more accessible to licensed healthcare providers or organisations. It comprises two advanced ultrasound transducers, an app-based online portal and a subscription platform as part of a comprehensive portable, connected digital solution.

Philips Philips Minicare system

In the area of cardiac care, the Philips Minicare system, a handheld testing platform, is able to show blood test results on the reader display within minutes, potentially speeding up cardiovascular disease diagnosis. The system offers multiplexing capabilities, making it possible to improve diagnostic and provide multiple marker results, simultaneously, from the same sample.

Shedding light on the future of personalised cancer care

Philips held a roundtable discussion during Arab Health to address the challenges of cancer care in the region as well as raise awareness around the need to have an earlier cancer diagnosis.

Cancer accounts for more than ten per cent of all deaths in most Middle Eastern countries, and currently one in three women and one in two men are diagnosed globally with the disease in their lifetime. The region’s ageing and growing population will result in an increasing incidence of cancer by 2030. Arjen Radder, Philips CEO Middle East and Turkey, said: “Philips is addressing the growing need for a new approach to cancer care. We strive to deliver better, more personalised care to patients while reducing healthcare costs. This is done by constantly looking at better ways to locate cancers earlier, diagnosing them more precisely, making therapies more accurate with minimal invasive and taking a personalised approach in giving the patient the best possible care.

“Not only are we providing integrated ways to collect and analyse information but our clinical and biological expertise enables clinicians to interpret this data and choose the optimal treatment for the individual patient,” added Radder.

While the vast majority of cancer diagnoses are made or confirmed by a pathologist, the increased demand for pathology services continues to grow. Philips IntelliSite Pathology Solution and advanced visualisation helps care providers reach informed decisions through enhanced productivity with high resolution digital images, collaboration features and case management tools.

The roundtable included the signing of a memorandum of understanding (MoU) between Philips and the King Hussein Cancer Centre to collaborate more closely on fighting cancer in the Middle East. The MoU will see the two partners working together to implement cancer awareness campaigns, setting up continual medical education programmes relating to the practice oncology, and helping to improve quality assurances throughout the field.


“S-Cube” Operating Room by Starkstrom

Starkstrom officially launched its latest invention “the no corner modular operation room” during Arab Health. Starkstrom has been a pioneer in manufacturing medical infrastructure equipment for operation theaters for over 40 years. Combining technologies that create efficiency and utilizing the latest innovative technology is a key focus to Starkstrom. The creation of an operating room without angled 90 degree corners is the start of what will be a series of innovative designs and products that will launched in the coming years. The design will ultimately change the way operation theaters are made throughout the world and set a new standard in design.

After Starkstrom was acquired by Progility and as a result of the international expansion plan, the UK based company opened its first regional office in the Middle East in 2015 after opening 5 offices in India and Australia in an effort to further support the medical markets of the Middle East and Africa and to provide assistance to their existing customers in the region. Starkstrom believes that the launch of their new and innovative operation room could not have come at a better time. It is the only operation room that has been crafted using only one material: stainless steel: the panels, the ceiling, the edges, the cabinets and everything else are made out of 100% medical grade stainless steel.

The new no corner operation room is made of continuous stainless steel without any change of material in the corner making it extremely efficient and significantly improving infection control. Starkstrom’s latest innovation accompanied with its state of the art S-Cube modular panels has set a new standard in hospital operating theatre modular rooms. The S-Cube is a four panel system with each panel engineered to serve a specific purpose enabling users fast modifications at minimal costs. The S Cubes modular approach allows customer to continually adapt to the changing operating room environment.

Starkstrom’s commitment of continuously striving to improve the medical company that built the UK’s first control panel will continue to innovate for the years to come.


“Siemens launches ultrasound, X-ray systems

Siemens Healthcare presented a range of diagnostic imaging and therapy solutions at Arab Health 2016, also launching the company’s latest innovations – the Acuson NX3 Ultrasound system (see the Ultrasound section in this issue) and the Multitom Rax X-ray scanner.

The Healthcare industry globally is undergoing a drastic change, the Middle East being no exception. With a rapidly growing population, the demand for accessible and quality medical care has become more important than ever before. Under the motto ‘Making Healthcare Pay Off’ Siemens Healthcare demonstrates how its varied product portfolio supports healthcare providers in the Middle East, enabling them to overcome challenges and to achieve the goals and benchmarks set forth.

First Twin Robotic X-Ray system: Multitom Rax

The Multitom Rax (Robotic Advanced X-ray) system enables a wide variety of examinations in a range of clinical areas to be performed using only a single X-ray system for the first time. The operator is always in full control of the system’s movement. By the push of a button, both robotic arms are positioned fully automatically around the patient, improving both safety and convenience. There is no need to move the patient on the system or to change rooms for further imaging procedures, which makes examinations less painful and less time-consuming.

MRI systems

The new 1.5-tesla scanner Magnetom Amira offers the same technologies that are available on the Siemens flagship MRI systems. Magnetom Amira also stands out against other scanners on account of its lower operating costs. By combining high image quality with comparatively low costs per scan, Magnetom Amira meets the requirements of radiology practices, small and medium-sized hospitals and larger facilities that are looking for a system to complement their existing devices.

Computed Tomography

The Somatom Force, third generation of Dual Source computed tomography (CT scanners each with two radiation tubes and detectors) enables considerably quicker and more precise diagnoses at reduced doses. This high-end CT offers individualized diagnoses now especially also for challenging patients, e.g. for very young patients or people suffering from renal insufficiency, the seriously ill, and obese patients.

Cloud-based healthcare network teamplay

With the vision of helping healthcare experts connect and utilize the wealth of medical imaging data, Siemens Healthcare presented teamplay. This cloudbased network helps link hospitals and healthcare experts to provide them with the ability to exchange data and pool their knowledge.


Record UK presence at Arab Health

Arab Health 2016 attracted the biggest ever UK presence of clinicians, medical technology companies and hospitals. Over 200 UK companies from England, Scotland, Wales and Northern Ireland exhibited at the UK Pavilion, organised by the Association of British Healthcare Industries (ABHI).

The Pavilion was officially opened by Rt Hon Alistair Burt MP. The Minister of State for Community and Social Care commended the world-class innovators and renowned clinics from the UK who are working closely with countries across the Middle East to improve healthcare outcomes and efficiency. The Minister also launched a state-ofthe- art surgical simulation programme. The ‘surgical stage’ was specially constructed on-site to showcase cutting-edge collaborations between healthcare providers, clinicians and healthcare technology companies. Leading surgeons demonstrated complex surgical operations such as shoulder arthroscopy, external aortic root support and minimally invasive interventional cardiac procedures.

Burt, said: “The Middle Eastern healthcare market is benefiting from a rapid growth in investment, expected to be worth $60 billion by 2025. Arab Health provides UK exhibitors, including representatives from the NHS, a gateway to this industry and is an important event for them to promote their products, develop relationships and strengthen ties with countries in the Middle East.”


Advantech: ‘Distance no longer a barrier to healthcare’

Advantech showcased its latest telemedicine solutions at Arab Health 2016.

James Fan, Solution Architect Team Supervisor, Smart City Solutions Group, Advantech said they were heavily promoting the ‘AMiS’ series medical carts at the show and they had attracted a lot of interest.

Telemedicine is set to be one of the main healthcare industry trends this year.

“With telemedicine solutions, distance is no longer a barrier to healthcare. New devices and platforms that connect patients and doctors, as well as other involved parties including specialists, family members, insurers, and health and wellness coaches, to a vast array of information sources that extend their clinical reach are continually being created,” said Fan.

He added that in the GCC they had been focused on business in Qatar but hoped to develop business in Kuwait in 2016.

Advantech’s AMiS telemedicine carts support dual displays and multiple video inputs. Featuring a point-of-care (POC) medical computer and secondary display, they provide the ideal platform for virtual applications such as tele-consultation, tele-monitoring, and tele-visitation.

Fan said: “We are well established (the company was founded in 1983) and well known in critical care with our point-ofcare terminals, while we are relative newcomers in nursing. About two years ago, we released our trolleys, the difference being that we offer computerised trolleys – the computer is inside the cover or on top as a panel PC – giving hospitals the ability to have the same type hospital-wide. Our trolleys are set up specifically to accommodate multiple accessories, such as panels. So if a hospital is seeking a complete workstation, we are well positioned because that is our target end user: the caregiver who needs to bring multiple accessories to the patient.

“In the past we had a tablet, the MICA, which was developed together with Intel. This was too heavy and we now see a need for a pocketable tablet with Windows. The third aspect is patient infotainment – another area that involves bringing care to the patient’s bedside.”

Fan added: “The nursing cart supports Microsoft and has a high-definition camera for consultations. Most competing trolleys are too big, too wide and are stationed in the hallway, increasing the likelihood of mistakes. We want to bring the medication dispenser, all other accessories and the computer to the patient’s bedside so their health and medication can be safely monitored and electronically recorded.

“Mobile devices that support patient monitoring, data transfer, and wireless transmission are becoming increasingly common. Institutions are becoming increasingly interested in ideas about the technology of future healthcare, which include: increased connectivity, patient self-monitoring devices, cloud technologies, adoption of electronic health records (EHR), and more.”

Advantech’s AMiS cart and POC computers are designed to meet strict safety and reliability regulations and have secured UL60601-1 and EN60601-1 certifications. This ensures Advantech’s telemedicine carts can be employed in even the most critical environments, such as operating rooms, intensive care units, and emergency wards. Boasting a state-of-the-art design, the system features internally routed cables and DIN rails for accessories to facilitate intelligent upgrades and customisation in the future. Advantech’s AMiS telemedicine carts are also equipped with a long-lasting LiFePO4 battery that delivers stable, highperformance, and cost-effective power.

“Many hospitals are currently integrating telemedicine systems with existing medical carts to provide mobile telemedicine stations. However, this process involves numerous challenges related to cable routing, power supply, application requirements, etc. To address these issues, Advantech aims to develop an open platform that can satisfy hospitals’ current and future requirements,” said Harry Wang, Product Manager of AMiS, Advantech Medical Computing Group.

Advantech also showcased its clinical mobility, critical care, emergency fleet management, patient services, and hospital public spaces solutions developed together with its channel partners, IT solution providers UAE-based Al Minhaj Computers and Emitac Healthcare and the Taiwan Institute for Information Industry.

Medical tablets

Advantech medical tablets range between 5, 7, and 10 inches in size. The tablets demonstrated included MIT-W101 and MICA- 071. In addition to meeting strict industry regulations, the MIT-W101 is compatible with diverse accessories and module options, allowing customers to customise the system according to their needs. The MICA-071 7” tablet with 1D/2D barcode scanner and Microsoft 10 is specifically designed to support clinical environments, healthcare applications, and hospital procedures.


Roche Diagnostics Middle East; an unrivaled leader at Arab Health 2016

 

Once again, Roche Diagnostics Middle East was front and centre at the 41st edition of Arab Health Exhibition and Congress with an impressive booth and lounge displaying powerful solutions highlighting the look and feel of a future laboratory. Roche’s booth was the talk of the exhibition as it raised the bar for corporate branding. Under the theme of “Innovation, Automation and Patient Care”, the level of detail to communicating these key messages at every corner of the booth was unmatched. With over 10,000 delegates in participation, the stream of traffic on the booth showed no signs of slowing down from opening day until the concluding afternoon. Its unique elements sparked the interest of all to stop by and experience what everyone was talking about.

Commenting on RDME’s participation in the Arab Health Exhibition & Congress 2016, Moritz Hartmann, General Manager of RDME said: “Arab Health provides the perfect launch pad for these innovative instruments, as diagnostics have become one of the most influential elements in healthcare provision. That’s why we strive through our continuous innovation to constantly increase testing efficiency, workflow integration, and breadth of diagnosis – enabling labs to provide test results while increasing accuracy and speed, thus empowering healthcare professionals and their patients to make informed decisions that are appropriate for them and their treatment journey.”

Doing now what patients need next

Innovation is at the core of what we do at Roche. Curiosity and openness to unconventional ideas are the building blocks of our intense activity in the field of advanced technology. In fact, we envision continuous progress as an opportunity to ultimately benefit patients. Roche Diagnostics seized the opportunity to showcase the latest technologies on opening day of the exhibition by displaying the newly unveiled cobas e 801 module for immunology testing is a platform capable of carrying out double the number of tests compared with the previous versions e 601 and e 602, within the same laboratory space. The system requires smaller blood samples, making it particularly suitable for the diagnosis of vulnerable patients such as newborn babies, those with cancer, and the elderly.

The star of the show was the cobas c 513 – a high-throughput HbA1c analyzer – which can assess sugar levels for the last three months, making it suitable for diagnosis and monitoring of diabetes patients. Recent figures from the International Diabetes Federation show that almost 37 million people in the MENA region have diabetes, which if left unchecked could more than double by 2035.

“The increasing number of people with diabetes is challenging healthcare providers and is putting a significant strain on healthcare systems,” Hartmann said. “With the cobas c 513, Roche Diagnostics is meeting the growing testing needs of our customers in the Middle East and ultimately improving patient care,” he added.


Revolutionary new cardiac procedure for Marfan Syndrome debuts in Middle East

During February’s Arab Health conference held in Dubai, Mr Ulrich Rosendahl, Cardiac Surgeon at Royal Brompton & Harefield Hospitals (RB&HH), London performed a live simulation of the innovative ExoVasc Personalised External Aortic Root Support (PEARS) procedure – a less invasive method of preventing dilatation, dissection and rupture of the aortic root
and ascending aorta.

The surgery was developed to assist patients with Marfan syndrome, a genetic disorder that affects the body’s connective tissue and therefore a person’s ability to grow and develop properly. This PEARS simulation was the first to be seen anywhere in the Middle East.

Globally, around one in 5,000 people are affected by Marfan syndrome and this figure is consistent in the Middle East, highlighting the importance and impact of such innovative treatments being introduced into the Middle East, and across the world.

In a move to drive awareness of lifesaving cardiac surgeries and share expertise of its treatments, Royal Brompton & Harefield Hospitals has performed cardiac procedures for the last two years during the Arab Health conference, the most recent being the less invasive surgery for patients with an enlarged aortic root and ascending aorta.

The hospital’s goal is to have trained surgeons across the Middle East so that PEARS can be performed and given to those suffering with the disease in the most efficient manner. As part of its drive to raise awareness in the Middle East and across the world, the hospital is looking to find centres where the procedure can be exported.

Once a patient is confirmed suitable for the procedure, a 3D printed physical model is produced based on the dimensions of their aorta. A mesh sleeve is then tailored to these exact dimensions.

In the PEARS procedure the aortic valve is not removed or repaired, which avoids the need for lifelong anticoagulation therapy. Instead, the mesh sleeve is placed around the ascending aorta where it provides support to the patient’s own aorta and aortic valve and is designed to prevent enlargement and rupture. It takes a relatively short time to implant, around two hours for the full surgery – a conventional aortic root replacement, usually takes around 4 to 7 hours. Using PEARS, a cardiopulmonary bypass is not usually necessary as the procedure is carried out on the beating heart.

Mr Rosendahl said: “The PEARS procedure is currently performed in the UK for those in the Middle East, and will continue to be. By visiting the region, we are working to share our information and expertise to bring the Middle East one step closer to offering the procedure for those with Marfan syndrome at home.

“This knowledge sharing and training is with the aim of vastly improving the life of those with the syndrome. The procedure provides an exciting, less intrusive and viable option for those in the Middle East with the disease.”


King’s College Hospital Dubai unveils core specialties

At Arab Health Exhibition & Congress the latest details of Kings College Hospital, Dubai were shared in a high-level discussion between the Dubai Health Authority (DHA), the UK Minister of State for Health, King’s College Hospital London (KCH) and its Dubai and UK investors including Ashmore Group, Al Tayer and Dubai Investments.

King’s College Hospital, Dubai, a 100-bed multi-speciality hospital set to open in 2018 at the heart of the premium community ‘Dubai Hills’, and its several day-care clinics, set to open in 2017, will be a centre of excellence for four main specialities; Obstetrics & Gynaecology, Paediatrics, Orthopaedics and Endocrinology, leveraging King’s College Hospital London’s world-leading position in these therapeutic areas.

H.E. Ahmed H. Al Tayer, Chairman, said: “We are delighted to be bringing to Dubai a world class multi-speciality hospital. The hospital will contribute to the UAE strategy and vision of becoming a health tourism destination. With the world leading capability of our partners King’s College, patients will be able to receive the highest standards of treatment right here in Dubai, and we are proud to be part of bringing the ‘Best of British’ healthcare to the country.”

Simon Taylor, Managing Director responsible for King’s College Hospital international operations said: “King’s College Hospital, Dubai will offer centres of excellence in four therapeutic areas with deep tertiary capabilities in addition to delivering first class general care as a full-service hospital. The hospital will be equipped with state-of-the-art technology and equipment, and some of the UK’s leading physicians and speciality clinical staff will lead clinical delivery on site. The hospital will be fully integrated with our London facilities across all areas of clinical governance and capabilities, providing the full range of King’s services and experience to UAE residents.”


130 French companies take part at exhibition

130 French companies took part in Arab Health 2016. With 1,440 sqm in exhibition space across two halls, one entirely dedicated to laboratory equipment and diagnostics, the trade show offered a prime venue from them to show off their know-how. Business France – the National Agency for the Internationalization of French Business which supports them, reported recordhigh registration levels for this year’s event.

The French medical equipment industry is powered by cutting-edge companies, 94% of which are SMEs, or even VSEs.

French manufacturers are focused on diagnostic imaging tools, disposable systems, implants, prostheses and orthotics. Their innovative tools are used in two main growth markets: aging surgery and plastic surgery. They also enjoy wide recognition in the fields of technical assistance, minimally-invasive surgery and in-vitro diagnostics. French companies came to the show with the help of regional partners such as CENTRECO, Lille Eurasanté, Biomédical Alliance and the Aquitaine Region

Highlights

  • BIOLABO introduced SOLEA 100, an analyzer for haemostasis capable of performing over 100 tests per hour. Featuring an exclusive 8-channel cuvette system, it is fast, reliable and cost-effective.
  • Cosmosoft presented ReduStim, a class IIa medical device for abdominal fat reduction. Its innovative approach aims to eliminate fat through biomagnetic field activation. The French company has been designing, manufacturing and distributing slimming equipment and professional medical devices for over 15 years.
  • Solsteo manufactures industrial sterilizers and guarantees its sterilization chambers for 10 years. This guarantee is given in full confidence because their design has been independently validated by the TÜV. The manufacturing process is complex and requires in-depth-understanding of the sterilization process and safety standards governing their use. Only a handful of manufacturers prove reliable. Determined to succeed on the international scene, Solsteo is the only French manufacturer exporting their product.
  • Holtex has specialised in the manufacturing and sale of medical equipment in France and overseas for more than 25 years. Holtex has a range of more than 15 medical products from medical furniture, diagnostic devices, medical wear, medical bags, consumables, etc.
  • Trading Point showed off its two trademark products: Perfect’Slim and Ginseng Royal Jelly. It was this company’s first appearance at the Arab Health Show. For almost 20 years, the specialist in food supplements has been offering items that are ready for use, in standard and customized forms, made exclusively in France. Private label development is its core business.

In Brief

Medical, Welch Allyn and the rest of the Hill-Rom portfolio. Hill- Rom’s core brands work together in five clinical focus areas for the company – advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency and respiratory health.

The company exhibited a range of ICU and medical/surgical bed systems designed to maximise patient safety and caregiver efficiency, along with operating room innovations from Trumpf Medical such as the user-friendly operating table TruSystem 7000, and the Connex Spot Monitor from Welch Allyn.

“Leveraging the extensive portfolio of Hill-Rom across the healthcare spectrum, from the doctor’s office to the operating room through to acute care, allows institutions across the region to optimise their facilities to meet the growing demands stemming from the local healthcare trends and enhance outcomes for both patients and caregivers,” said Carlos Alonso, Senior Vice-President and President, International at Hill-Rom.

Luxurious, private rehabilitation centre launched in Dubai

At Arab Health, JCI reaccredited, Canadian Specialist Hospital (CSH) launched the first private in-patient rehabilitation centre in Dubai in partnership with Wagner Health & Care, a leading provider of rehabilitation services from Austria. The AED 35 million (US$10 million) centre will provide 48 beds in super luxurious rooms for its medium and long term in-patient services in addition to its outpatient and day services.

“We realized that there was a huge gap in the country and the region with regard to world class rehabilitation centres. For this reason, many patients from UAE travel to Europe and Asian countries for such treatments. We wanted to bring the best to the UAE. and tied-up with Austria’s Wagner


Health & Care to cater to the immediate needs of patients in UAE,” said Dr Yashar Ali, Acting CEO & Chief Medical Officer of CSH.

The centre will provide rehabilitation services for the following fields orthopedics, metabolic diseases, cardiology, neurology and oncology. A multi-disciplinary team of physiotherapists, occupational therapists, speech therapists, nutritionist and medical psychologists will offer various therapies, such as back school, vocational counseling, electrotherapy, thermal therapy, nutrition counseling and different types of massages.

Full range of pressure mattress solutions

UK pressure ulcer specialist Rober, showcased their full range of mattress solutions which cater to a variety of patients’ needs from everyday nursing environments to acute care facilities.

The pioneering range of mattresses and overlays – which includes solutions for immobile, critically ill and bariatric patients – have been developed in conjunction with clinicians and feature clinically proven technology that prevents pressure injuries from developing. They also promote the healing of established ulcers. The mattresses are fully automatic and patients nursed upon them require less manual repositioning. Designed to mechanically replicate the body’s natural spontaneous movement in response to unrelieved pressure, they provide regular and complete pressure elimination to all parts of the body in contact with the mattress.

The company has focused on four key areas – microclimate control, patient safety and comfort, maximising infection control and offering additional nursing support. Two mattress ranges are available from Rober, the premium ‘NoDec’ range and the coteffective ‘AirFlex’.


Date of upload: 15th Mar 2016

 

                                  
                                               Copyright © 2016 MiddleEastHealthMag.com. All Rights Reserved.